My Favorite Holiday Gift Ideas for Your Loved Ones with Parkinson’s
Every year, I compile a list of holiday gift ideas for people with Parkinson’s disease. This year, I’ve taken my favorites from previous lists ... Read more
Updates
-
Alpha-synuclein Blood Levels May Be Biomarker for Parkinson’s with Motor Symptoms
Measuring the levels of alpha-synuclein in red blood cells can reliably distinguish people with Parkinson’s disease and evident motor symptoms from healthy individuals, and could serve ... Read more -
First DUB Enzymes Identified by Partnership as Potential Therapeutic Targets for Parkinson’s and Alzheimer’s
Mission Therapeutics and AbbVie have identified several molecules, called deubiquitylating enzymes, or DUBs, that may be potential therapeutic targets to treat Parkinson’s and Alzheimer’s ... Read more -
Cerevance’s Phase 2 Trial Recruiting Patients to Test Oral CVN424 Therapy for Motor Symptoms
Cerevance has initiated a Phase 2 clinical trial to evaluate the safety and efficacy of its oral investigational therapy CVN424 for treating Parkinson’s disease ... Read more -
Novartis’ Tasigna Fails to Show Clinically Meaningful Benefits in Parkinson’s, Phase 2 Trial Shows
Tasigna (nilotinib), an approved leukemia medication being tested as a repurposed treatment for Parkinson’s disease, failed to show any clinically meaningful benefits in a ... Read more
-
Phase 2 Study to Evaluate Possible Oral Treatment for Mild Cognitive Impairment in Parkinson’s
Aptinyx will soon open a Phase 2 clinical study of NYX-458, a potential oral ... -
Falls and Poor Bone Health Top Reasons for High Fracture Risk in Parkinson’s, Study Says
People with Parkinson’s disease are at elevated risk of hip and non-vertebral fractures mostly ... -
Understanding What Parkinson’s Progression Means to Each Patient
Every day following the ruin of stagnation, it seems that I have progressed from ... -
Deep Brain Stimulation May Impair Swimming Ability and Increase Risk of Drowning, Case Studies Suggest
Patients who undergo deep brain stimulation to treat Parkinson’s disease may lose their ability ... -
Dosing Begins in Phase 2 Trial of CNM-Au8, Potential Therapy for Dopaminergic Neurons
A pilot Phase 2 study evaluating CNM-Au8, an investigational Parkinson’s treatment aiming to protect nerve cells, ...
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
New Tool Effectively Monitors Sleep Quality in Parkinson’s Patients, Researchers Say
News
A new tool called cardiopulmonary coupling could be used to effectively evaluate sleep quality in Parkinson’s disease patients, who often experience sleep disorders, according to a study. The study, “Assessment of sleep quality using cardiopulmonary coupling analysis in patients with ... Read more